Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Bio Tech Limited has informed the stock exchanges that its trading window will remain closed starting Tuesday, 1st July 2025. The window will stay shut until 48 hours after the company announces its unaudited financial results for the quarter ended 30th June 2025 (Q1 FY26). This closure is as per the company's internal code of conduct and SEBI's Prohibition of Insider Trading Regulations, 2015. Designated persons, including directors and key employees, are barred from trading in the company's shares during this period. The intimation was signed by Ms. Dimpy Joshi, Company Secretary and Compliance Officer.
This is a routine regulatory compliance announcement and does not directly impact shareholders. However, the upcoming Q1 FY26 results could be a catalyst for stock price movement once the trading window reopens after the results are announced.